News - Page 226 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

Psyched Wellness Has Commenced Research on Muscimol for Various Ailments

Post published:December 28, 2020
Post category:Press Release

Read more about the article Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value

Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value

Post published:December 28, 2020
Post category:Press Release

Read more about the article First Psychedelic ETF Expected to Launch January 2021 (NEO:PSYK)

First Psychedelic ETF Expected to Launch January 2021 (NEO:PSYK)

Post published:December 28, 2020
Post category:Analysis News

Read more about the article Entheon Biomedical Closes Private Placement

Entheon Biomedical Closes Private Placement

Post published:December 26, 2020
Post category:Press Release

Read more about the article Novamind Completes Reverse Takeover Transaction

Novamind Completes Reverse Takeover Transaction

Post published:December 24, 2020
Post category:Press Release

Read more about the article Red Light Holland Announces Exercise of Warrants for Gross Proceeds of Over $5 Million

Red Light Holland Announces Exercise of Warrants for Gross Proceeds of Over $5 Million

Post published:December 24, 2020
Post category:Press Release

Read more about the article Lobe Sciences Announces Upsizing and First Closing of Non-brokered Private Placement

Lobe Sciences Announces Upsizing and First Closing of Non-brokered Private Placement

Post published:December 24, 2020
Post category:Press Release

Read more about the article Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Post published:December 23, 2020
Post category:Press Release

Read more about the article Ehave KetaDASH Subsidiary Announces Intent to Battle Major Depression through Home Delivery of Ketamine

Ehave KetaDASH Subsidiary Announces Intent to Battle Major Depression through Home Delivery of Ketamine

Post published:December 23, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Plans on Emergency Use Access

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Plans on Emergency Use Access

Post published:December 23, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.